Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform

ABSTRACT:

SUBMITTER: Zheng B 

PROVIDER: S-EPMC10624988 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature